on Onco-Innovations Limited (CVE:ONCO)
Onco-Innovations to Lead Key Oncology Forum on Precision Medicine
Onco-Innovations Limited's subsidiary, Inka Health Corp., will chair a vital roundtable as part of Colorectal Cancer Canada's "Catalysts: Innovating for Tomorrow Series." This event, set to occur in the fall, will focus on data innovation and digital trust in oncology. This initiative underscores Onco-Innovations' growing role in shaping crucial discussions around cancer care.
The roundtable, led by Inka Health Co-Founder Dr. Paul Arora, will address topics such as artificial intelligence integration and secure data sharing. It aims to explore the use of emerging data sources to advance precision medicine globally. This reflects the pressing need for healthcare systems to adopt new technologies responsibly.
Expert participation includes Dr. Steve Jones, Dr. Winson Cheung, and Inka Health Co-Founder Alind Gupta. Their insights are expected to strengthen Onco-Innovations' leadership through substantial partnerships and influence in AI-enabled healthcare.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Onco-Innovations Limited news